This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Institut Gustave Roussy. Active years: 2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2017
Title: Innovator in Oncology: Dalil Hannani
Introduction: Dalil Hannani is a prominent inventor located in Villejuif, France, known for his innovative contributions to cancer treatment. He specializes in the development of methods that improve the efficacy of immunotherapy for patients suffering from tumors. His work reflects a significant advancement in the field of oncology, particularly in understanding how to predict patient responses to immunotherapeutic treatments.
Latest Patents: Dalil Hannani holds a patent titled "Methods for predicting the sensitivity of a subject to immunotherapy." This invention outlines a novel approach for assessing, predicting, and monitoring the sensitivity of individuals with tumors or cancer to immunotherapeutic molecules that target T cells. The procedure involves measuring the expression level of soluble CD25 (sCD25) in biological samples from patients and comparing these levels to established reference levels. This method aids in determining whether a patient is likely to respond positively or resist immunotherapy, enhancing the ability to personalize cancer treatment plans effectively.
Career Highlights: Dalil Hannani is currently associated with the prestigious Institut Gustave Roussy, a leading center for cancer care and research in France. His work at this institution focuses on pushing the boundaries of cancer treatment through innovative methodologies and clinical applications derived from his research and patents.
Collaborations: Throughout his career, Dalil has collaborated with esteemed colleagues, including Laurence Zitvogel and Caroline Robert. These collaborations bring together a wealth of knowledge and expertise in cancer research, further contributing to the development of effective treatments for patients.
Conclusion: Dalil Hannani exemplifies the spirit of innovation in the medical field, particularly in oncology. His patented methods for predicting sensitivities to immunotherapy not only pave the way for more effective cancer treatments but also signify the importance of research and collaboration in achieving breakthrough solutions in healthcare. Through his contributions, Dalil continues to make a profound impact on the future of cancer therapy.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile